Vfend and malaise Patient Reports February 12, 2012

Vfend Side Effects Report #4831642-7
Vfend side effect was reported by a Physician from FRANCE on Nov 03, 2005. Female patient, 66 years of age, weighting 154.3 lb, was diagnosed with systemic candida and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood culture positive, cardiac arrest , malaise, sinus bradycardia, syncope. Vfend dosage: 200 MG (5 IN 1 D), INTRAVENOUS. During the same period patient was treated with CORTICOSTEROIDS. Patient recovered.

Vfend Side Effects Report #4844900-7
Vfend side effect was reported by a Physician from JAPAN on Nov 15, 2005. Male patient, 75 years of age, was diagnosed with mycotic corneal ulcer, ulcerative keratitis and was treated with Vfend. After drug was administered, patient experienced the following side effects: corneal epithelium disorder, gamma-glutamyltransferase increased, malaise. Vfend dosage: 6 MG/KG, INTRAVENOUS. During the same period patient was treated with FLUCONAZOLE, PRODIF, FUNGUARD, GATIFLO, PIMARICIN. Patient recovered.

Vfend Side Effects Report #4847640-3
Vfend side effect was reported by a Physician from JAPAN on Nov 22, 2005. Male patient, 75 years of age, was diagnosed with mycotic corneal ulcer, ulcerative keratitis and was treated with Vfend. After drug was administered, patient experienced the following side effects: cardiac failure, cardiac valve disease, corneal epithelium disorder, corneal perforation, fluid retention, gamma-glutamyltransferase increased, malaise, nasopharyngitis, weight increased. Vfend dosage: 6MG/KG, INTRAVENOUS. During the same period patient was treated with FLUCONAZOLE, PRODIF, MICAFUNGIN, GATIFLOXACIN, NATAMYCIN. Patient recovered.

Vfend Side Effects Report #5161771-2
Vfend side effect was reported by a Physician from JAPAN on Nov 08, 2006. Male patient, 74 years of age, weighting 114.4 lb, was diagnosed with fungal infection  and was treated with Vfend. After drug was administered, patient experienced the following side effects: depressed level of consciousness, hepatic function abnormal, hyponatraemia, malaise, somnolence. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ALDACTONE, MICARDIS, ROXATIDINE ACETATE, PREDNISOLONE, BIO THREE, FUNGIZONE, POVIDONE IODINE, ACTONEL. Patient was hospitalized. Patient recovered.


Vfend Side Effects Report #4783667-8
Vfend side effect was reported by a Physician from JAPAN on Sept 15, 2005. Male patient, 79 years of age, was diagnosed with bronchopulmonary aspergillosis, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest , dyspnoea, encephalopathy, hypoglycaemia, loss of consciousness, malaise, mental disorder, pyrexia. Vfend dosage: 400 MG, INTRAVENOUS. During the same period patient was treated with CIPROXAN CIPROFLOXACIN). Patient recovered.

Vfend Side Effects Report #4788816-3
Vfend side effect was reported by a Physician from JAPAN on Sept 21, 2005. Male patient, 79 years of age, was diagnosed with bronchopulmonary aspergillosis, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest , dyspnoea, encephalopathy, hypoglycaemia, loss of consciousness, malaise, mental disorder, pyrexia. Vfend dosage: 400 MG , INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE. Patient died on 09/01/2005.

Vfend Side Effects Report #4803532-7
Vfend side effect was reported by a Physician from JAPAN on Oct 04, 2005. Male patient, 79 years of age, was diagnosed with bronchopulmonary aspergillosis, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest , dyspnoea, loss of consciousness, malaise, pyrexia, toxic induced encephalopathy. Vfend dosage: 400 MG INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, CLARITH. Patient died on 09/01/2005.

Vfend Side Effects Report #5128302-4
Vfend side effect was reported by a Physician from JAPAN on Sept 28, 2006. Female patient, 71 years of age, weighting 108.9 lb, was diagnosed with bronchopulmonary aspergillosis, lung neoplasm malignant and was treated with Vfend. After drug was administered, patient experienced the following side effects: gamma-glutamyltransferase increased, hepatic function abnormal, malaise, nausea , oral intake reduced. Vfend dosage: 400 MG (2 IN 1 D), ORAL; 300 MG, INTRAVENOUS. During the same period patient was treated with TAXOTERE, PARAPLATIN, ITRACONAZOLE. Patient recovered.

Vfend Side Effects Report #5165043-1
Vfend side effect was reported by a Physician from JAPAN on Nov 13, 2006. Male patient, 16 years of age, weighting 93.70 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: malaise, myalgia, pneumonia , pyrexia. Vfend dosage: 600 MG (300 MG, 2 IN 1 D), ORAL. During the same period patient was treated with FUNGIZONE, SULFAMETHOXAZOLE, MEROPEN. Patient was hospitalized. Patient recovered.


Vfend Side Effects Report #5917969-6
Vfend side effect was reported by a Physician from JAPAN on Oct 02, 2008. Male patient, weighting 101.4 lb, was diagnosed with bronchopulmonary aspergillosis, pneumonia necrotising, cough and was treated with Vfend. After drug was administered, patient experienced the following side effects: anorexia, dizziness , fall , hallucination, liver disorder, malaise, nausea , visual impairment. Vfend dosage: unknown. During the same period patient was treated with FLAVERIC, ANTIBIOTICS, MEROPENEM TRIHYDRATE, CIPROFLOXACIN HYDROCHLORIDE. Patient recovered.

Vfend Side Effects Report #4933608-5
Vfend side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 16, 2006. Female patient, 69 years of age, weighting 114.0 lb, was diagnosed with aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: atrial fibrillation , gastric ulcer haemorrhage, hepatic failure, international normalised ratio increased, malaise, multi-organ failure, renal failure, white blood cell count increased. Vfend dosage: 80 MG (40 MG, 2 IN 1 D), ORAL. During the same period patient was treated with XOPENEX, SPIRVA, ADVAIR DISKUS, COLACE, METOPROLOL, MAGNESIUM OXIDE, LEVAQUIN, ROCEPHIN. Patient recovered.

Vfend Side Effects Report #4830578-5
Vfend side effect was reported by a Physician from FRANCE on Nov 03, 2005. Female patient, 15 years of age, was diagnosed with aspergillosis, ill-defined disorder, nausea  and was treated with Vfend. After drug was administered, patient experienced the following side effects: anxiety , cardiac arrest , chest discomfort, dyspnoea, electrocardiogram qt prolonged, hypomagnesaemia, malaise, mucormycosis. Vfend dosage: 600 MG (300 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with POSACONAZOLE, IMIDAZOLE SALICYLATE, OMEPRAZOLE, AMBISOME, CANCIDAS, MYCOSTATIN, AMPHOTERICIN B. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #4868779-2
Vfend side effect was reported by a Physician from FRANCE on Dec 12, 2005. Female patient, 15 years of age, was diagnosed with aspergillosis, ill-defined disorder, nausea  and was treated with Vfend. After drug was administered, patient experienced the following side effects: anxiety , cardiac arrest , chest discomfort, dyspnoea, electrocardiogram qt prolonged, hypomagnesaemia, malaise, mucormycosis. Vfend dosage: 600 MG (300 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with POSACONAZOLE, IMIDAZOLE SALICYLATE, OMEPRAZOLE, AMBISOME, CANCIDAS, MYCOSTATIN, AMPHOTERICIN B. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #4943830-X
Vfend side effect was reported by a Physician from FRANCE on Feb 27, 2006. Female patient, 15 years of age, was diagnosed with aspergillosis, ill-defined disorder, nausea  and was treated with Vfend. After drug was administered, patient experienced the following side effects: anxiety , cardiac arrest , cardiovascular disorder, dyspnoea, electrocardiogram qt prolonged, hypomagnesaemia, malaise, pallor. Vfend dosage: 600 MG (300 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with POSACONAZOLE, IMIDAZOLE SALICYLATE, OMEPRAZOLE, AMBISOME, CANCIDAS, MYCOSTATIN, AMPHOTERICIN B, NYSTATINE. Patient was hospitalized. Patient recovered.


Vfend Side Effects Report #4901170-9
Vfend side effect was reported by a Physician from JAPAN on Jan 19, 2006. Male patient, 76 years of age, was diagnosed with aspergilloma, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood potassium decreased, contraindication to medical treatment, dizziness , dysstasia, malaise, parkinson's disease , pyrexia. Vfend dosage: unknown. During the same period patient was treated with HALCION, FLUCONAZOLE, LENDORM. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #4844676-3
Vfend side effect was reported by a Physician from FRANCE on Nov 14, 2005. Female patient, 17 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vfend. After drug was administered, patient experienced the following side effects: abnormal behaviour, aggression, hallucination, auditory, hallucination, visual, malaise. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with CILASTATIN W. Patient was hospitalized. Patient recovered.